<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-pharmaceutics-12-00388">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yotnda</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Chiu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Piedra</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Templeton</surname>
    <given-names>N.S.</given-names>
   </name>
   <name>
    <surname>Brenner</surname>
    <given-names>M.K.</given-names>
   </name>
  </person-group>
  <article-title>Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses</article-title>
  <source>Mol. Ther.</source>
  <year>2002</year>
  <volume>5</volume>
  <fpage>233</fpage>
  <lpage>241</lpage>
  <pub-id pub-id-type="doi">10.1006/mthe.2002.0545</pub-id>
  <pub-id pub-id-type="pmid">11863412</pub-id>
 </element-citation>
</ref>
